ARCOSA INC (ACA) Stock Fundamental Analysis
USA - NYSE:ACA - US0396531008 - Common Stock
98.7 USD
-1.85 (-1.84%)
98.7 USD
0 (0%)
Overall ACA gets a fundamental rating of 5 out of 10. We evaluated ACA against 55 industry peers in the Construction & Engineering industry. ACA has only an average score on both its financial health and profitability. ACA is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
ACA had positive earnings in the past year.
In the past year ACA had a positive cash flow from operations.
Each year in the past 5 years ACA has been profitable.
Each year in the past 5 years ACA had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.84%, ACA is in line with its industry, outperforming 47.27% of the companies in the same industry.
The Return On Equity of ACA (3.68%) is worse than 60.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.09%, ACA is in line with its industry, outperforming 45.45% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ACA is significantly below the industry average of 17.19%.
The 3 year average ROIC (3.99%) for ACA is below the current ROIC(4.09%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 3.68% | ||
| ROIC | 4.09% |
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
1.3 Margins
With a Profit Margin value of 3.45%, ACA perfoms like the industry average, outperforming 56.36% of the companies in the same industry.
In the last couple of years the Profit Margin of ACA has declined.
With a decent Operating Margin value of 8.93%, ACA is doing good in the industry, outperforming 69.09% of the companies in the same industry.
ACA's Operating Margin has declined in the last couple of years.
ACA's Gross Margin of 20.82% is fine compared to the rest of the industry. ACA outperforms 63.64% of its industry peers.
ACA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.93% | ||
| PM (TTM) | 3.45% | ||
| GM | 20.82% |
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACA is destroying value.
ACA has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ACA has been increased compared to 5 years ago.
ACA has a worse debt/assets ratio than last year.
2.2 Solvency
ACA has an Altman-Z score of 2.25. This is not the best score and indicates that ACA is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of ACA (2.25) is comparable to the rest of the industry.
The Debt to FCF ratio of ACA is 5.72, which is a neutral value as it means it would take ACA, 5.72 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ACA (5.72) is comparable to the rest of the industry.
ACA has a Debt/Equity ratio of 0.67. This is a neutral value indicating ACA is somewhat dependend on debt financing.
ACA has a Debt to Equity ratio (0.67) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 5.72 | ||
| Altman-Z | 2.25 |
ROIC/WACC0.41
WACC10.06%
2.3 Liquidity
A Current Ratio of 2.12 indicates that ACA has no problem at all paying its short term obligations.
ACA's Current ratio of 2.12 is amongst the best of the industry. ACA outperforms 89.09% of its industry peers.
A Quick Ratio of 1.35 indicates that ACA should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.35, ACA is in the better half of the industry, outperforming 65.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.35 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 17.03% over the past year.
ACA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.16% yearly.
The Revenue has grown by 11.35% in the past year. This is quite good.
The Revenue has been growing by 8.15% on average over the past years. This is quite good.
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
Revenue 1Y (TTM)11.35%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%
3.2 Future
The Earnings Per Share is expected to grow by 20.31% on average over the next years. This is a very strong growth
ACA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.30% yearly.
EPS Next Y36.06%
EPS Next 2Y24.91%
EPS Next 3Y20.31%
EPS Next 5YN/A
Revenue Next Year10.62%
Revenue Next 2Y8.3%
Revenue Next 3Y7.3%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 26.11, ACA can be considered very expensive at the moment.
Based on the Price/Earnings ratio, ACA is valued a bit cheaper than the industry average as 72.73% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 25.67. ACA is around the same levels.
With a Price/Forward Earnings ratio of 21.02, ACA is valued on the expensive side.
ACA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ACA is cheaper than 78.18% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ACA to the average of the S&P500 Index (31.86), we can say ACA is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.11 | ||
| Fwd PE | 21.02 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ACA indicates a somewhat cheap valuation: ACA is cheaper than 80.00% of the companies listed in the same industry.
ACA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ACA is cheaper than 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.45 | ||
| EV/EBITDA | 14.14 |
4.3 Compensation for Growth
ACA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ACA's earnings are expected to grow with 20.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.72
PEG (5Y)5.06
EPS Next 2Y24.91%
EPS Next 3Y20.31%
5. Dividend
5.1 Amount
ACA has a yearly dividend return of 0.20%, which is pretty low.
Compared to an average industry Dividend Yield of 1.73, ACA pays a better dividend. On top of this ACA pays more dividend than 81.82% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, ACA's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.2% |
5.2 History
The dividend of ACA decreases each year by -0.48%.
ACA has been paying a dividend for over 5 years, so it has already some track record.
ACA has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)-0.48%
Div Incr Years0
Div Non Decr Years5
5.3 Sustainability
10.63% of the earnings are spent on dividend by ACA. This is a low number and sustainable payout ratio.
DP10.63%
EPS Next 2Y24.91%
EPS Next 3Y20.31%
98.7
-1.85 (-1.84%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)
Earnings (Next)
Inst Owners95.34%
Inst Owner Change-2.1%
Ins Owners1.8%
Ins Owner Change6.34%
Market Cap4.84B
Revenue(TTM)2.57B
Net Income(TTM)92.20M
Analysts86
Price Target118.32 (19.88%)
Short Float %2.38%
Short Ratio5.47
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.2% |
Yearly Dividend0.2
Dividend Growth(5Y)-0.48%
DP10.63%
Div Incr Years0
Div Non Decr Years5
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)89.94%
Min EPS beat(2)17.65%
Max EPS beat(2)162.24%
EPS beat(4)3
Avg EPS beat(4)36.02%
Min EPS beat(4)-40.32%
Max EPS beat(4)162.24%
EPS beat(8)7
Avg EPS beat(8)29.61%
EPS beat(12)11
Avg EPS beat(12)31.83%
EPS beat(16)15
Avg EPS beat(16)40.43%
Revenue beat(2)1
Avg Revenue beat(2)-0.94%
Min Revenue beat(2)-3.72%
Max Revenue beat(2)1.83%
Revenue beat(4)1
Avg Revenue beat(4)-3.36%
Min Revenue beat(4)-7.1%
Max Revenue beat(4)1.83%
Revenue beat(8)3
Avg Revenue beat(8)-0.98%
Revenue beat(12)7
Avg Revenue beat(12)0.67%
Revenue beat(16)11
Avg Revenue beat(16)2.34%
PT rev (1m)0%
PT rev (3m)3.73%
EPS NQ rev (1m)0.33%
EPS NQ rev (3m)3.96%
EPS NY rev (1m)0.23%
EPS NY rev (3m)4.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.6%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.75%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.11 | ||
| Fwd PE | 21.02 | ||
| P/S | 1.81 | ||
| P/FCF | 16.45 | ||
| P/OCF | 10.91 | ||
| P/B | 1.93 | ||
| P/tB | 5.76 | ||
| EV/EBITDA | 14.14 |
EPS(TTM)3.78
EY3.83%
EPS(NY)4.7
Fwd EY4.76%
FCF(TTM)6
FCFY6.08%
OCF(TTM)9.05
OCFY9.17%
SpS54.56
BVpS51.15
TBVpS17.14
PEG (NY)0.72
PEG (5Y)5.06
Graham Number65.96
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 3.68% | ||
| ROCE | 5.33% | ||
| ROIC | 4.09% | ||
| ROICexc | 4.27% | ||
| ROICexgc | 6.98% | ||
| OM | 8.93% | ||
| PM (TTM) | 3.45% | ||
| GM | 20.82% | ||
| FCFM | 11% |
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
ROICexc(3y)4.17%
ROICexc(5y)4.21%
ROICexgc(3y)7.17%
ROICexgc(5y)7.33%
ROCE(3y)5.21%
ROCE(5y)5.27%
ROICexgc growth 3Y4.01%
ROICexgc growth 5Y-10.09%
ROICexc growth 3Y4.98%
ROICexc growth 5Y-11.63%
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 5.72 | ||
| Debt/EBITDA | 3.68 | ||
| Cap/Depr | 69.44% | ||
| Cap/Sales | 5.59% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 97.67% | ||
| Profit Quality | 319.09% | ||
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.35 | ||
| Altman-Z | 2.25 |
F-Score5
WACC10.06%
ROIC/WACC0.41
Cap/Depr(3y)104.81%
Cap/Depr(5y)89.02%
Cap/Sales(3y)7.45%
Cap/Sales(5y)6.15%
Profit Quality(3y)128.08%
Profit Quality(5y)133.99%
High Growth Momentum
Growth
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
EPS Next Y36.06%
EPS Next 2Y24.91%
EPS Next 3Y20.31%
EPS Next 5YN/A
Revenue 1Y (TTM)11.35%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%
Revenue Next Year10.62%
Revenue Next 2Y8.3%
Revenue Next 3Y7.3%
Revenue Next 5YN/A
EBIT growth 1Y27.67%
EBIT growth 3Y20.99%
EBIT growth 5Y5.01%
EBIT Next Year133.35%
EBIT Next 3Y37.6%
EBIT Next 5YN/A
FCF growth 1Y717.22%
FCF growth 3Y56.55%
FCF growth 5Y2.7%
OCF growth 1Y103.53%
OCF growth 3Y44.47%
OCF growth 5Y6.95%
ARCOSA INC / ACA FAQ
Can you provide the ChartMill fundamental rating for ARCOSA INC?
ChartMill assigns a fundamental rating of 5 / 10 to ACA.
What is the valuation status for ACA stock?
ChartMill assigns a valuation rating of 5 / 10 to ARCOSA INC (ACA). This can be considered as Fairly Valued.
Can you provide the profitability details for ARCOSA INC?
ARCOSA INC (ACA) has a profitability rating of 5 / 10.
What are the PE and PB ratios of ARCOSA INC (ACA) stock?
The Price/Earnings (PE) ratio for ARCOSA INC (ACA) is 26.11 and the Price/Book (PB) ratio is 1.93.
What is the expected EPS growth for ARCOSA INC (ACA) stock?
The Earnings per Share (EPS) of ARCOSA INC (ACA) is expected to grow by 36.06% in the next year.